Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	endopolyphosphatase activity	NUDT11 NUDT3 NUDT10	4.71e-06	5	157	3	GO:0000298
GeneOntologyMolecularFunction	bis(5'-adenosyl)-hexaphosphatase activity	NUDT11 NUDT3 NUDT10	4.71e-06	5	157	3	GO:0034431
GeneOntologyMolecularFunction	diphosphoinositol-polyphosphate diphosphatase activity	NUDT11 NUDT3 NUDT10	4.71e-06	5	157	3	GO:0008486
GeneOntologyMolecularFunction	bis(5'-adenosyl)-pentaphosphatase activity	NUDT11 NUDT3 NUDT10	9.37e-06	6	157	3	GO:0034432
GeneOntologyMolecularFunction	GTPase binding	DOCK1 PPP1R9A PLEKHG3 RABGAP1L CDC42EP2 AKAP13 FGD5 RAB11FIP4 GOLGA4 PKN3 SORL1	1.35e-04	360	157	11	GO:0051020
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	DOCK1 ARHGEF12 ARHGAP4 PLEKHG3 RABGAP1L EIF2B5 CDC42EP2 KIAA1755 AKAP13 SH3BP5L FGD5 PLXNB1 TBCD	1.91e-04	507	157	13	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	DOCK1 ARHGEF12 ARHGAP4 PLEKHG3 RABGAP1L EIF2B5 CDC42EP2 KIAA1755 AKAP13 SH3BP5L FGD5 PLXNB1 TBCD	1.91e-04	507	157	13	GO:0030695
GeneOntologyMolecularFunction	small GTPase binding	DOCK1 PLEKHG3 RABGAP1L CDC42EP2 AKAP13 FGD5 RAB11FIP4 GOLGA4 PKN3 SORL1	2.34e-04	321	157	10	GO:0031267
GeneOntologyMolecularFunction	transcription factor binding	SETD1A WIPI1 AKAP8 FLYWCH1 E4F1 ARID1A IKZF4 HNRNPU PASD1 ZNHIT6 PER2 ARNT2 DOT1L BSN LEF1 HDAC1	2.99e-04	753	157	16	GO:0008134
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DOCK1 ARHGEF12 PLEKHG3 EIF2B5 KIAA1755 AKAP13 SH3BP5L FGD5	4.96e-04	231	157	8	GO:0005085
GeneOntologyMolecularFunction	RNA cap binding	LARP1 NCBP3 EIF4A1	5.72e-04	21	157	3	GO:0000339
GeneOntologyMolecularFunction	dATP binding	ST13 ST13P5	6.05e-04	5	157	2	GO:0032564
GeneOntologyMolecularFunction	adenyl deoxyribonucleotide binding	ST13 ST13P5	9.03e-04	6	157	2	GO:0032558
GeneOntologyMolecularFunction	histone deacetylase binding	MIER2 MAGEA9 AKAP8 PER2 LEF1 HDAC1	1.09e-03	147	157	6	GO:0042826
GeneOntologyMolecularFunction	transcription corepressor binding	PER2 BSN LEF1 HDAC1	1.20e-03	59	157	4	GO:0001222
GeneOntologyMolecularFunction	purine deoxyribonucleotide binding	ST13 ST13P5	1.26e-03	7	157	2	GO:0032554
GeneOntologyMolecularFunction	protein domain specific binding	DOCK1 CACNB1 PPP1R9A BAK1 SKP1 ST13 IKZF4 AXIN1 AFAP1L1 EHD2 ZNF592 SAMD11 ROBO1 ST13P5 LEF1 HDAC1	1.48e-03	875	157	16	GO:0019904
GeneOntologyBiologicalProcess	regulation of synapse assembly	DOCK1 PODXL PPP1R9A CRTAC1 CC2D1A PTPRD PTPRS PRKCA ROBO1 ADGRE5	3.49e-06	202	157	10	GO:0051963
GeneOntologyBiologicalProcess	adenosine 5'-(hexahydrogen pentaphosphate) metabolic process	NUDT11 NUDT3 NUDT10	4.28e-06	5	157	3	GO:1901910
GeneOntologyBiologicalProcess	adenosine 5'-(hexahydrogen pentaphosphate) catabolic process	NUDT11 NUDT3 NUDT10	4.28e-06	5	157	3	GO:1901911
GeneOntologyBiologicalProcess	diadenosine pentaphosphate catabolic process	NUDT11 NUDT3 NUDT10	4.28e-06	5	157	3	GO:1901907
GeneOntologyBiologicalProcess	diadenosine pentaphosphate metabolic process	NUDT11 NUDT3 NUDT10	4.28e-06	5	157	3	GO:1901906
GeneOntologyBiologicalProcess	diadenosine hexaphosphate catabolic process	NUDT11 NUDT3 NUDT10	4.28e-06	5	157	3	GO:1901909
GeneOntologyBiologicalProcess	diadenosine hexaphosphate metabolic process	NUDT11 NUDT3 NUDT10	4.28e-06	5	157	3	GO:1901908
GeneOntologyBiologicalProcess	diphosphoinositol polyphosphate metabolic process	NUDT11 NUDT3 NUDT10	4.28e-06	5	157	3	GO:0071543
GeneOntologyBiologicalProcess	synapse assembly	DOCK1 PODXL PPP1R9A CRTAC1 CC2D1A PTPRD PTPRS PRKCA ROBO1 ADGRE5 BSN PLXNB1	4.39e-06	308	157	12	GO:0007416
GeneOntologyBiologicalProcess	diadenosine polyphosphate catabolic process	NUDT11 NUDT3 NUDT10	8.51e-06	6	157	3	GO:0015961
GeneOntologyBiologicalProcess	diadenosine polyphosphate metabolic process	NUDT11 NUDT3 NUDT10	3.51e-05	9	157	3	GO:0015959
GeneOntologyBiologicalProcess	regulation of cellular component biogenesis	DOCK1 ABCA3 WIPI1 PODXL PPP1R9A BAK1 CRTAC1 CC2D1A CEP192 HNRNPU PTPRD RNF5 TRAPPC12 PTPRS CDC42EP2 CHMP3 PRKCA ROBO1 ADGRE5 CX3CL1 TBCD SORL1	1.00e-04	1189	157	22	GO:0044087
GeneOntologyBiologicalProcess	regulation of cell junction assembly	DOCK1 PODXL PPP1R9A CRTAC1 CC2D1A PTPRD PTPRS PRKCA ROBO1 ADGRE5	1.33e-04	309	157	10	GO:1901888
GeneOntologyBiologicalProcess	activation of cysteine-type endopeptidase activity	BAD BAK1 NLRP6	1.84e-04	15	157	3	GO:0097202
HumanPheno	Atrophic muscularis propria	POLG RRM2B TYMP	1.93e-06	4	41	3	HP:0025149
HumanPheno	Abnormal intestinal smooth muscle morphology	POLG RRM2B TYMP	1.93e-06	4	41	3	HP:0030935
HumanPheno	Scoliosis	AMER1 PLOD3 USB1 PODXL POLG RRM2B FLVCR1 INTS1 WDR81 CHD3 ARID1A RYR1 RFWD3 HNRNPU FANCE ARVCF TRAPPC12 CC2D2A HSPB8 UNC80 TBCD KIF22	8.95e-06	1122	41	22	HP:0002650
HumanPheno	Small intestinal dysmotility	POLG RRM2B TYMP	9.52e-06	6	41	3	HP:0012850
HumanPheno	Decreased number of large peripheral myelinated nerve fibers	POLG RRM2B TYMP HSPB8	1.59e-05	20	41	4	HP:0003387
HumanPheno	Abnormal curvature of the vertebral column	AMER1 PLOD3 USB1 PODXL POLG RRM2B FLVCR1 INTS1 WDR81 CHD3 ARID1A RYR1 RFWD3 HNRNPU FANCE ARVCF TRAPPC12 CC2D2A HSPB8 UNC80 TBCD KIF22	3.64e-05	1219	41	22	HP:0010674
HumanPheno	Reduced tissue thymidine phosphorylase activity	POLG TYMP	6.32e-05	2	41	2	HP:6000570
HumanPheno	Elevated circulating deoxyuridine concentration	POLG TYMP	6.32e-05	2	41	2	HP:0034277
HumanPheno	Elevated circulating thymidine concentration	POLG TYMP	6.32e-05	2	41	2	HP:0034276
HumanPheno	Decreased sensory nerve conduction velocity	POLG RRM2B FLVCR1 TYMP	6.43e-05	28	41	4	HP:0003448
HumanPheno	Abnormal sensory nerve conduction velocity	POLG RRM2B FLVCR1 TYMP	7.42e-05	29	41	4	HP:0040132
HumanPheno	Multiple mitochondrial DNA deletions	POLG RRM2B TYMP	7.64e-05	11	41	3	HP:0003689
HumanPheno	Gastroparesis	PODXL POLG RRM2B TYMP	1.41e-04	34	41	4	HP:0002578
HumanPheno	Hyperactive bowel sounds	POLG TYMP	1.89e-04	3	41	2	HP:0030143
HumanPheno	Abnormality of the bladder	POLG RRM2B FLVCR1 RYR1 RFWD3 HNRNPU FANCE ARVCF TRAPPC12 ARNT2 CC2D2A ROBO1 STRA6 TBCD	2.08e-04	621	41	14	HP:0000014
HumanPheno	Hypomimic face	PODXL POLG RRM2B CC2D1A	2.42e-04	39	41	4	HP:0000338
HumanPheno	Macrovesicular hepatic steatosis	POLG RRM2B TYMP	3.04e-04	17	41	3	HP:0001403
HumanPheno	Abnormal cerebrospinal fluid morphology	AMER1 POLG RRM2B WDR81 GCDH TYMP RFWD3 HNRNPU FANCE ARVCF TRAPPC12 EIF2B5 CC2D2A ROBO1	3.16e-04	646	41	14	HP:0002921
HumanPheno	Abnormal neurological laboratory findings	AMER1 POLG RRM2B FLVCR1 WDR81 GCDH TYMP RYR1 RFWD3 HNRNPU FANCE ARVCF TRAPPC12 EIF2B5 CC2D2A ROBO1 HSPB8 UNC80	3.28e-04	1000	41	18	HP:0003129
HumanPheno	Abnormal tracheal morphology	AMER1 USB1 POLG RFWD3 FANCE ARNT2 KIF22	3.51e-04	170	41	7	HP:0002778
HumanPheno	Abnormal cell morphology	POLG RRM2B TYMP RYR1	3.55e-04	43	41	4	HP:0025461
HumanPheno	Abnormal circulating pyrimidine concentration	POLG TYMP FANCE	3.63e-04	18	41	3	HP:0004353
HumanPheno	Depletion of mitochondrial DNA in muscle tissue	POLG RRM2B TYMP	4.29e-04	19	41	3	HP:0009141
Pathway	REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL	NUDT11 NUDT3 NUDT10	6.25e-05	10	116	3	MM14709
Pathway	REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL	NUDT11 NUDT3 NUDT10	6.25e-05	10	116	3	M27051
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TFEB SETD1A PLOD3 POLG INTS1 PFAS CC2D1A CEP192 ARID1A BIRC6 RYR1 FAM83H PPP1R26 PER2 ARVCF ZNF592 TRAPPC12 PTPRS NLRC5 TP53I13 AKAP13 SH3BP5L DOT1L SYVN1 PKN3 TBCD	8.56e-12	1105	160	26	35748872
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SECISBP2L NOL6 ZNF629 LARP1 PFAS CHD3 RFWD3 HNRNPU KLHL11 ZNHIT6 ARVCF EIF4A1 EIF2B5 AKAP13 PLXNB1 SORL1	6.24e-08	650	160	16	38777146
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TFEB NES AMER1 USP22 AKAP8 BAD ZNF629 LARP1 CC2D1A CEP192 FAM83H SAMD11 PLEKHG3 RABGAP1L AKAP13 BOD1L1 SH3BP5L GOLGA4	1.04e-07	861	160	18	36931259
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NES CACNB1 NYAP2 AKAP8 PPP1R9A WDR81 ARHGEF12 PPFIA3 SKP1 FBXO2 HNRNPU UBE2O PTPRD ARVCF PTPRS EIF4A1 PRKCA BSN GOLGA4	1.10e-07	963	160	19	28671696
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	DOCK1 AMER1 AKAP8 PFAS USP37 SKP1 HNRNPU FAM83H PER2 AKAP13	1.36e-07	232	160	10	25515538
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP22 AKAP8 MAP1A ZNF212 RALYL ZNF629 APBA2 GCDH CHD3 PPFIA3 ARID1A SKP1 FAM83H ARHGAP4 ZNHIT6 ZNF592 UNC80 INO80B HDAC1 SORL1	2.32e-07	1116	160	20	31753913
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	NES AKAP8 WDR33 LARP1 BIRC6 AFAP1L1 UBE2O CUEDC2 TRAPPC12 ARNT2 ROBO1 AKAP13 BOD1L1 SH3BP5L GOLGA4 PKN3	3.14e-07	733	160	16	34672954
Pubmed	Nudix hydrolases that degrade dinucleoside and diphosphoinositol polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP) pyrophosphatase activity that generates the glycolytic activator ribose 1,5-bisphosphate.	NUDT11 NUDT3 NUDT10	3.81e-07	4	160	3	12370170
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TFEB MAP1A WDR33 ZNF629 BAK1 PFAS CEP192 ARID1A SKP1 ST13 SH3BP5L DOT1L BSN SORL1	6.43e-07	588	160	14	38580884
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	PODXL INTS1 PFAS GCDH AFAP1L1 PPP1R26 ARHGAP4 UBE2O ZNHIT6 TRAPPC12 EIF2B5 AKAP13 FGD5 TBCD KIF22	7.74e-07	689	160	15	36543142
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRD PTPRS BSN	9.49e-07	5	160	3	22357843
Pubmed	Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.	AMER1 SKP1 AXIN1 LEF1	9.80e-07	17	160	4	17510365
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	AMER1 PLOD3 WDR33 BAD LARP1 FBXO11 PFAS ARID1A SKP1 AXIN1 HNRNPU FAM83H NUDT11 ARVCF EIF4A1 ZNF511 DOT1L LEF1 HDAC1 KIF22	1.30e-06	1247	160	20	27684187
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	EXOSC10 AKAP8 NOL6 ZNF629 LARP1 FBXO11 CHD3 BIRC6 HNRNPU NCBP3 EIF4A1 EIF2B5 DGCR8 HDAC1 KIF22	2.54e-06	759	160	15	35915203
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TFEB EXOSC10 AKAP8 FLYWCH1 WDR33 INTS1 FNBP4 ZNF629 FBXO11 CHD3 NCAPH2 E4F1 ARID1A SKP1 RFWD3 HNRNPU PWWP2A HDAC1 KIF22	8.64e-06	1294	160	19	30804502
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SETD1A ZNF629 ARHGEF12 PFAS PER2 ARNT2	9.03e-06	104	160	6	9205841
Pubmed	DNA damage-induced activation of ATM promotes β-TRCP-mediated ARID1A ubiquitination and destruction in gastric cancer cells.	ARID1A SKP1 FBXO2	1.12e-05	10	160	3	31210753
Pubmed	FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.	FBXO11 SKP1 NLRC5	1.53e-05	11	160	3	37279268
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	NES APBA2 ARHGEF12 ITIH2 NUDT11 ARVCF NUDT10 CHMP3	1.98e-05	246	160	8	15345747
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	SETD1A AKAP8 FBXO11 CHD3 SKP1 FBXO2 PWWP2A UBE2O BOD1L1 INO80B HDAC1	2.01e-05	495	160	11	27705803
Pubmed	Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.	PPFIA3 PTPRD PTPRS	2.04e-05	12	160	3	9624153
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PPP1R9A ARHGEF12 CEP192 TRIL PER2 RABGAP1L BOD1L1 SH3BP5L RAB11FIP4 SYVN1	2.07e-05	407	160	10	12693553
Pubmed	BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A.	SETD1A BOD1L1	2.10e-05	2	160	2	38989615
Pubmed	Interplay between DOT1L and HDAC1 regulates Leishmania donovani infection in human THP-1 cells.	DOT1L HDAC1	2.10e-05	2	160	2	39103111
Pubmed	DGCR8 Acts as an Adaptor for the Exosome Complex to Degrade Double-Stranded Structured RNAs.	EXOSC10 DGCR8	2.10e-05	2	160	2	26687677
Pubmed	Paralogous murine Nudt10 and Nudt11 genes have differential expression patterns but encode identical proteins that are physiologically competent diphosphoinositol polyphosphate phosphohydrolases.	NUDT11 NUDT10	2.10e-05	2	160	2	12689335
Pubmed	Energetics of OCP1-OCP2 complex formation.	SKP1 FBXO2	2.10e-05	2	160	2	18284940
Pubmed	An α-helical C-terminal tail segment of the skeletal L-type Ca2+ channel β1a subunit activates ryanodine receptor type 1 via a hydrophobic surface.	CACNB1 RYR1	2.10e-05	2	160	2	22962299
Pubmed	A novel F box protein, NFB42, is highly enriched in neurons and induces growth arrest.	SKP1 FBXO2	2.10e-05	2	160	2	9857061
Pubmed	Modulation of p120E4F transcriptional activity by the Gam1 adenoviral early protein.	E4F1 HDAC1	2.10e-05	2	160	2	12730668
Pubmed	St13 protects against disordered acinar cell arachidonic acid pathway in chronic pancreatitis.	ST13 ST13P5	2.10e-05	2	160	2	35562743
Pubmed	An adjacent pair of human NUDT genes on chromosome X are preferentially expressed in testis and encode two new isoforms of diphosphoinositol polyphosphate phosphohydrolase.	NUDT11 NUDT10	2.10e-05	2	160	2	12105228
Pubmed	Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L-dose dependency in HDAC1-deficient thymic lymphoma.	DOT1L HDAC1	2.10e-05	2	160	2	31304633
Pubmed	Intramolecular ex vivo Fluorescence Resonance Energy Transfer (FRET) of Dihydropyridine Receptor (DHPR) β1a Subunit Reveals Conformational Change Induced by RYR1 in Mouse Skeletal Myotubes.	CACNB1 RYR1	2.10e-05	2	160	2	26114725
Pubmed	Mitochondrial Neurogastrointestinal Encephalopathy Disease	POLG TYMP	2.10e-05	2	160	2	20301358
Pubmed	Positive association of CC2D1A and CC2D2A gene haplotypes with mental retardation in a Han Chinese population.	CC2D1A CC2D2A	2.10e-05	2	160	2	22023432
Pubmed	Identifying and treating ROBO1-ve /DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients.	DOCK1 ROBO1	2.10e-05	2	160	2	32687658
Pubmed	Amino acid residues 489-503 of dihydropyridine receptor (DHPR) β1a subunit are critical for structural communication between the skeletal muscle DHPR complex and type 1 ryanodine receptor.	CACNB1 RYR1	2.10e-05	2	160	2	25384984
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	2.10e-05	2	160	2	9566880
Pubmed	Erythropoietin modulation of podocalyxin and a proposed erythroblast niche.	EPOR PODXL	2.10e-05	2	160	2	17403918
Pubmed	Active Bax and Bak are functional holins.	BAD BAK1	2.10e-05	2	160	2	22006182
Pubmed	Structural basis for the selection of glycosylated substrates by SCF(Fbs1) ubiquitin ligase.	SKP1 FBXO2	2.10e-05	2	160	2	17389369
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	EXOSC10 AKAP8 NOL6 FNBP4 LARP1 CHD3 ARID1A HNRNPU NCBP3 ZNF592 EIF4A1 HDAC1	2.57e-05	605	160	12	28977666
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIER2 FLYWCH1 INTS1 CHD3 NCBP3 PWWP2A UBE2O ZNF592 BOD1L1 DOT1L HDAC1 KIF22	2.70e-05	608	160	12	36089195
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	DOCK1 AMER1 USP37 SKP1 AXIN1 HNRNPU	2.95e-05	128	160	6	25332235
Pubmed	Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model.	NES DGCR8 LEF1	3.35e-05	14	160	3	24101523
Pubmed	FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress.	FBXO11 SKP1 FBXO2	3.35e-05	14	160	3	23319600
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1A NYAP2 FLYWCH1 ZNF212 FNBP4 LARP1 ARHGAP4 UBE2O ZNF592 BSN PLXNB1	3.68e-05	529	160	11	14621295
Pubmed	Ranbp1, Deleted in DiGeorge/22q11.2 Deletion Syndrome, is a Microcephaly Gene That Selectively Disrupts Layer 2/3 Cortical Projection Neuron Generation.	NES ARVCF PRKCA DGCR8	3.83e-05	41	160	4	25452572
Pubmed	Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells.	TFEB AKAP8 ARID1A HNRNPU HDAC1 KIF22	3.97e-05	135	160	6	31077711
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD1A EXOSC10 PLOD3 AKAP8 RRM2B NOL6 FNBP4 LARP1 ARID1A ZNF592	4.00e-05	440	160	10	34244565
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	PLOD3 AKAP8 PPP1R9A ZNF629 LARP1 HNRNPU NCBP3 EIF4A1	4.26e-05	274	160	8	34244482
Pubmed	NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway.	BAD ARHGEF12 ARHGAP4 AKAP13	4.63e-05	43	160	4	12376548
Pubmed	A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.	DOCK1 WDR81 NUDT11 NUDT10 NLRC5 UNC80 HDAC1	4.86e-05	205	160	7	12040188
Pubmed	Receptor protein tyrosine phosphatases are expressed by cycling retinal progenitor cells and involved in neuronal development of mouse retina.	NES PTPRS PRKCA	5.12e-05	16	160	3	18308476
Pubmed	Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).	CHD3 ARID1A HDAC1	5.12e-05	16	160	3	11784859
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD1A EXOSC10 WDR33 FNBP4 LARP1 CC2D1A ARID1A UBE2O BOD1L1 DOT1L HDAC1	5.14e-05	549	160	11	38280479
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETD1A NES EXOSC10 NOL6 PFAS ARID1A SKP1 BIRC6 HNRNPU FAM83H ARVCF PLEKHG3 EIF4A1 EIF2B5 PRKCA AKAP13 HSPB8 GOLGA4	5.49e-05	1353	160	18	29467282
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MAP1A ARHGEF12 PFAS CEP192 AXIN1 UBE2O ROBO1	5.49e-05	209	160	7	36779422
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 AMER1 POLG FLVCR1 PPP1R9A BAD FNBP4 LARP1 CHD3 CEP192 ARID1A HNRNPU PTPRS PLEKHG3 NLRC5 AKAP13 BOD1L1 GOLGA4 TBCD	5.87e-05	1489	160	19	28611215
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	DOCK1 AKAP8 RALYL INTS1 LARP1 FBXO11 GCDH HNRNPU NCBP3 DGCR8	6.00e-05	462	160	10	31138677
Pubmed	Protein tyrosine phosphatases expression during development of mouse superior colliculus.	NES PTPRD PTPRS	6.20e-05	17	160	3	19727691
Pubmed	Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia.	POLG RRM2B	6.29e-05	3	160	2	32161153
Pubmed	Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.	BAD BAK1	6.29e-05	3	160	2	28937296
Pubmed	Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator.	LEF1 HDAC1	6.29e-05	3	160	2	10958684
Pubmed	Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors.	ARHGEF12 PLXNB1	6.29e-05	3	160	2	12220504
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRS	6.29e-05	3	160	2	31985401
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRS	6.29e-05	3	160	2	20139422
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRS	6.29e-05	3	160	2	33656439
Pubmed	Interaction between the dihydropyridine receptor Ca2+ channel beta-subunit and ryanodine receptor type 1 strengthens excitation-contraction coupling.	CACNB1 RYR1	6.29e-05	3	160	2	16357209
Pubmed	The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG.	ARHGEF12 PLXNB1	6.29e-05	3	160	2	12196628
Pubmed	Mito-protective autophagy is impaired in erythroid cells of aged mtDNA-mutator mice.	EPOR POLG	6.29e-05	3	160	2	25411424
Pubmed	Human CD1D gene expression is regulated by LEF-1 through distal promoter regulatory elements.	LEF1 HDAC1	6.29e-05	3	160	2	20363964
Pubmed	DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells.	ARID1A SKP1	6.29e-05	3	160	2	26400522
Pubmed	The Neuronal Migration Factor srGAP2 Achieves Specificity in Ligand Binding through a Two-Component Molecular Mechanism.	ARHGAP4 ROBO1	6.29e-05	3	160	2	26365803
Pubmed	X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer.	AXIN1 HDAC1	6.29e-05	3	160	2	23110995
Pubmed	Rapamycin-enhanced mitomycin C-induced apoptotic death is mediated through the S6K1-Bad-Bak pathway in peritoneal carcinomatosis.	BAD BAK1	6.29e-05	3	160	2	24901052
Pubmed	Kaiso is a bimodal modulator for Wnt/beta-catenin signaling.	AXIN1 HDAC1	6.29e-05	3	160	2	19166851
Pubmed	Absence of the beta subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the alpha 1 subunit and eliminates excitation-contraction coupling.	CACNB1 RYR1	6.29e-05	3	160	2	8943043
Pubmed	Fbxo2 mediates clearance of damaged lysosomes and modifies neurodegeneration in the Niemann-Pick C brain.	SKP1 FBXO2	6.29e-05	3	160	2	32931479
Pubmed	The Structural Differences between a Glycoprotein Specific F-Box Protein Fbs1 and Its Homologous Protein FBG3.	SKP1 FBXO2	6.29e-05	3	160	2	26460611
Pubmed	LEF-1 activates the transcription of E2F1.	LEF1 HDAC1	6.29e-05	3	160	2	17980157
Pubmed	Mouse models of age-related mitochondrial neurosensory hearing loss.	POLG BAK1	6.29e-05	3	160	2	22820179
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRS	6.29e-05	3	160	2	9784606
Pubmed	A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak·Bcl-xl Complex and Triggering Transcriptional Regulation.	BAD BAK1	6.29e-05	3	160	2	26668309
Pubmed	M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression.	BAD BAK1	6.29e-05	3	160	2	16978419
Pubmed	Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families.	APOA5 SORL1	6.29e-05	3	160	2	18603531
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	6.29e-05	3	160	2	25394468
Pubmed	Cloning and characterisation of hAps1 and hAps2, human diadenosine polyphosphate-metabolising Nudix hydrolases.	NUDT11 NUDT10	6.29e-05	3	160	2	12121577
Pubmed	ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.	ARID1A HDAC1	6.29e-05	3	160	2	31913353
Pubmed	The cochlear F-box protein OCP1 associates with OCP2 and connexin 26.	SKP1 FBXO2	6.29e-05	3	160	2	15109709
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	EXOSC10 AMER1 AKAP8 PODXL FLVCR1 NOL6 CC2D1A CEP192 BIRC6 CDC42EP2 ROBO1 DGCR8 GOLGA4	6.77e-05	777	160	13	35844135
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	DOCK1 NES WDR33 ARHGEF12 SKP1 ST13 ARHGAP4 PLEKHG3 ROBO1 AKAP13 FGD5 GOLGA4 PKN3 SORL1	9.25e-05	916	160	14	32203420
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	POLG APBA2 FBXO11 CRTAC1 NCAPH2 CLIC6 ARID1A ST13 CREBZF UBE2O PTPRD ZNF592 EIF4A1 CHMP3 ROBO1 DGCR8 RAB11FIP4	9.55e-05	1285	160	17	35914814
Pubmed	The protein interaction landscape of the human CMGC kinase group.	TFEB CACNB1 AKAP8 WDR33 WDR81 LARP1 SKP1 AXIN1 NCBP3 DGCR8 JHY SORL1	9.66e-05	695	160	12	23602568
Pubmed	Functional proteomics mapping of a human signaling pathway.	USB1 FNBP4 CHD3 E4F1 ST13 CREBZF PPP1R26 ZNHIT6 ZNF592 CHMP3 TBCD	9.87e-05	591	160	11	15231748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L MIER2 ZNF629 PFAS USP37 BIRC6 PPP1R26 PWWP2A PLEKHG3 UNC80	1.02e-04	493	160	10	15368895
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PLOD3 FLVCR1 PPP1R9A PFAS CEP192 PPFIA3 ARID1A SKP1 BIRC6 PTPRD ARVCF PTPRS ROBO1 GOLGA4 KIF22	1.08e-04	1049	160	15	27880917
Pubmed	The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.	AKAP8 LARP1 HNRNPU NCBP3	1.23e-04	55	160	4	31640799
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	SECISBP2L AMER1 PLOD3 AKAP8 PFAS GCDH NCAPH2 SKP1 FAM83H PKN3 TBCD	1.23e-04	606	160	11	36538041
Interaction	PLD1 interactions	MIER2 MAGEA9 APBA2 UBE2O PER2 EIF2B5 PRKCA DOT1L PKN3	9.21e-07	130	159	9	int:PLD1
Interaction	TOP3B interactions	TFEB SETD1A PLOD3 POLG RRM2B PPP1R9A INTS1 PFAS CC2D1A CEP192 ARID1A BIRC6 RYR1 HNRNPU FAM83H PPP1R26 PER2 ARVCF ZNF592 TRAPPC12 PTPRS EIF4A1 NLRC5 TP53I13 AKAP13 SH3BP5L DOT1L SYVN1 PKN3 TBCD	1.29e-06	1470	159	30	int:TOP3B
Interaction	NXF1 interactions	NES EXOSC10 USP22 AKAP8 MAP1A WDR33 PODXL NOL6 RALYL FNBP4 WDR81 PFAS CHD3 CEP192 XPNPEP1 SSR2 ARID1A CREBZF RFWD3 NCBP3 PPP1R26 TBCCD1 UBE2O NUDT3 RABGAP1L PRKCA HDAC1 KIF22	2.11e-06	1345	159	28	int:NXF1
Cytoband	1p36.22	EXOSC10 C1orf167 FBXO2	2.96e-04	37	160	3	1p36.22
Cytoband	Xp11.23	GAGE2A GAGE2B NUDT10 CHST7	3.53e-04	95	160	4	Xp11.23
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PPP1R9A WDR81 CEP192 RYR1 AXIN1 PPP1R26 MYO16	9.50e-05	181	106	7	694
GeneFamily	Nudix hydrolase family	NUDT11 NUDT3 NUDT10	3.62e-04	24	106	3	667
GeneFamily	Zinc fingers HIT-type	ZNHIT6 INO80B	5.03e-04	6	106	2	83
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF12 PLEKHG3 AKAP13 FGD5	6.08e-04	66	106	4	722
GeneFamily	C2 domain containing protein kinases	PRKCA PKN3	1.49e-03	10	106	2	835
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 HDAC1	2.16e-03	12	106	2	1305
GeneFamily	Fibronectin type III domain containing	EPOR PTPRD PTPRS ROBO1 SORL1	2.52e-03	160	106	5	555
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	TYMP AKAP13 PKN3	3.33e-03	51	106	3	870
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	FLYWCH1 BSN	3.40e-03	15	106	2	26
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	EPOR E4F1 PTPRD ROBO1 KIF22	2.50e-06	36	159	5	MM1284
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 EHD2 TRIL CDC42EP2 FGD5 PKN3	4.61e-07	193	158	8	5d42979d811ee13a07dee08a3743a90776017cb4
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 EHD2 TRIL CDC42EP2 FGD5 PKN3	4.61e-07	193	158	8	95e64b9580d30c28702639a043a8b72ce1cadeb6
ToppCell	droplet-Pancreas-Endocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 EHD2 TRIL CDC42EP2 FGD5 PKN3	4.61e-07	193	158	8	97c0730aad9135ac681250b3871cc094a28f80a7
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	FNBP4 APBA2 CHD3 HNRNPU ZNHIT6 PRKCA LEF1 SORL1	4.98e-07	195	158	8	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	AMER1 TBCCD1 NUDT11 PTPRS EIF2B5 CHST7 LEF1	4.32e-06	184	158	7	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	droplet-Pancreas-Endocrine-21m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 EHD2 CDC42EP2 FGD5 PKN3	5.16e-06	189	158	7	37ce47abd6f96df04d35a4a6189d007bef5ccc94
ToppCell	droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 EHD2 CDC42EP2 FGD5 PKN3	5.16e-06	189	158	7	b55324cb365a827d071952709bbf0e8ef8c313de
ToppCell	droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 EHD2 CDC42EP2 FGD5 PKN3	5.16e-06	189	158	7	62e46d59d3b89d4566b595c704d8b02f1ea9060b
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL ARHGEF12 AFAP1L1 NLRC5 FGD5 CX3CL1 PKN3	5.72e-06	192	158	7	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZBTB7C PODXL RALYL CRTAC1 ROBO1 FGD5 HSPB8	5.72e-06	192	158	7	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Vein\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZBTB7C PODXL RALYL CRTAC1 SAMD11 FGD5 PKN3	5.72e-06	192	158	7	717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL ARHGEF12 AFAP1L1 NLRC5 FGD5 CX3CL1 HSPB8	5.92e-06	193	158	7	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NES PODXL AFAP1L1 EHD2 CDC42EP2 CX3CL1 HSPB8	5.92e-06	193	158	7	aaf681f16f310168e4719464814a1fc0a2f8431a
ToppCell	critical-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PODXL CHD3 SSR2 ZNHIT6 PER2 CHMP3 SORL1	6.55e-06	196	158	7	dbf14f5851c2b779a8b35e820c4584ea9096e49d
ToppCell	Transverse-T_cell-Tfh\|T_cell / Region, Cell class and subclass	FLYWCH1 APBA2 PFAS CLIC6 PLEKHG3 RABGAP1L LEF1	7.23e-06	199	158	7	33ffea12b8228e0b5bd8942531c3b21d24224725
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CACNB1 ABCA3 AMER1 E4F1 C1orf167 NLRP6	2.01e-05	156	158	6	fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	INTS1 APBA2 CC2D1A NLRC5 HEMK1 LEF1	2.40e-05	161	158	6	2fe77af3b41e6eacb707a64feea18f9991618173
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	ABCA3 PTPRD PTPRS RABGAP1L ARNT2 CC2D2A	3.04e-05	168	158	6	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	facs\|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP22 PFAS TYMP BIRC6 NUDT3 SORL1	3.36e-05	171	158	6	c9990bc041a632b2f7bbebbfe737772c423d7027
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	APBA2 CRTAC1 EHD2 FANCE KLHL11 PTPRS	3.59e-05	173	158	6	ef8d720b99470fe1953661f6e66bc0366266bdb6
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_4\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 APBA2 FBXO2 EHD2 FANCE PTPRS	3.71e-05	174	158	6	110369f6b78de34a6d934b5b47cecd023347bc80
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Endothelial\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES NYAP2 PODXL CDC42EP2 FGD5 PKN3	4.48e-05	180	158	6	f9b7d5eb7b6ea72253c89bdc351ad2b4a53f7d8e
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|367C / Donor, Lineage, Cell class and subclass (all cells)	MIER2 NES PODXL AFAP1L1 CX3CL1 PKN3	4.48e-05	180	158	6	162cec1734e560c068cd61717e40e18dcf92308c
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Endothelial-endothelial_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES NYAP2 PODXL CDC42EP2 FGD5 PKN3	4.48e-05	180	158	6	53db6032eda0e590ae7e01c9c3b472785ea6782f
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Endothelial-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES NYAP2 PODXL CDC42EP2 FGD5 PKN3	4.48e-05	180	158	6	28bc10b9d0e4430b952260014d8a6ff337860ac6
ToppCell	367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	MIER2 NES PODXL AFAP1L1 CX3CL1 PKN3	4.48e-05	180	158	6	33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	NES PODXL ARHGEF12 AFAP1L1 FGD5 CX3CL1	4.62e-05	181	158	6	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITIH2 NUDT11 PTPRD ARNT2 NUDT10 MAP3K15	4.76e-05	182	158	6	f5f42e23832d0210560009ce6fd8eee89751e252
ToppCell	Control-Endothelial_cells-Endothelial_cells_(other)\|Control / group, cell type (main and fine annotations)	NES PODXL AFAP1L1 FGD5 CX3CL1 PKN3	5.37e-05	186	158	6	c6075fe84226b370c5139066793844ad33ae2db1
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PODXL HERC2P3 AFAP1L1 NLRC5 LEF1 PKN3	5.37e-05	186	158	6	422d24e3e1a9397bb7d5c7ef75de2fd7ae8e136d
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NES MAP1A NOL6 APBA2 PTPRS UNC80	5.37e-05	186	158	6	10565fce7e1b4ec88bc8e1ed6410a83800be5014
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PODXL HERC2P3 AFAP1L1 NLRC5 LEF1 PKN3	5.37e-05	186	158	6	65da0666a10a59f8cc379589860a2e98fe487754
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PODXL HERC2P3 AFAP1L1 NLRC5 LEF1 PKN3	5.37e-05	186	158	6	dc84fef1ca2f5d5d818b76a3321559e87d1c4a4d
ToppCell	facs-Aorta-Heart-3m-Endothelial-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL SYCE1L AFAP1L1 EHD2 FGD5	5.53e-05	187	158	6	df0279b7e94e26f5541b0e2a0ce56befa96ec8ca
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB7C MAP1A PODXL EHD2 FGD5 PKN3	5.53e-05	187	158	6	e93cad16a087d1443cbf4e1690dc1b35d7a84c41
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES ZBTB7C PODXL EHD2 FGD5 PKN3	5.70e-05	188	158	6	ec0e241de2c8310b4417b9d4e2420d7a1662f1c0
ToppCell	droplet-Kidney-nan-3m-Endothelial-kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL EHD2 FGD5 LEF1 PKN3	5.70e-05	188	158	6	67c04f446fa4528b13a381622e88eb1f314cc6d5
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SECISBP2L MAP1A CRTAC1 PTPRD RNF5 CDC42EP2	5.70e-05	188	158	6	87fd5e2dd01583baf7e018bff8750d20a557a20f
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	WIPI1 TRIL PTPRD PTPRS ROBO1 LEF1	5.70e-05	188	158	6	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 CDC42EP2 FGD5 PKN3	5.70e-05	188	158	6	05de6677f9bb4b00fed47f4b72f4a2cd507cb0f2
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	NES PODXL AFAP1L1 CDC42EP2 FGD5 CX3CL1	5.70e-05	188	158	6	fe7143c36e4a883745862d3c3147cf751b440e46
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|343B / Donor, Lineage, Cell class and subclass (all cells)	NES PODXL AFAP1L1 CDC42EP2 FGD5 CX3CL1	5.70e-05	188	158	6	cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437
ToppCell	droplet-Kidney-nan-3m-Endothelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL EHD2 FGD5 LEF1 PKN3	5.70e-05	188	158	6	03a7f6538cfddc230c0eab10c3613929addd7e33
ToppCell	droplet-Limb_Muscle-nan-18m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL AFAP1L1 EHD2 CDC42EP2 FGD5 PKN3	5.87e-05	189	158	6	a3f6ebd1622d36d114e42f6e0618d7b2fe8b9a2f
ToppCell	droplet-Limb_Muscle-nan-18m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL AFAP1L1 EHD2 CDC42EP2 FGD5 PKN3	5.87e-05	189	158	6	d86455cf20769d70d62e2c1dd92cbc93c67aada5
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 CDC42EP2 FGD5 PKN3	5.87e-05	189	158	6	8ced0381ea042ba47680a02b617a2368fa2c54c8
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SECISBP2L MAP1A CRTAC1 PTPRD RNF5 CDC42EP2	5.87e-05	189	158	6	bab0fe55643d3ee750355a32b1ff6634fa5cf88d
ToppCell	droplet-Mammary_Gland-nan-21m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NES PODXL AFAP1L1 CDC42EP2 FGD5 PKN3	5.87e-05	189	158	6	403a82bb416aed13b9d31411ad17bdc4ce2a95fb
ToppCell	droplet-Limb_Muscle-nan-18m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL AFAP1L1 EHD2 CDC42EP2 FGD5 PKN3	5.87e-05	189	158	6	84036d1257f6b18f47cfc7ac5e6ed6ea3553c235
ToppCell	facs-Pancreas-Exocrine-3m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL AFAP1L1 EHD2 TRIL FGD5 PKN3	6.04e-05	190	158	6	b7fc451e160e31dc898b122de844b501f587db67
ToppCell	facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL AFAP1L1 EHD2 TRIL FGD5 PKN3	6.04e-05	190	158	6	83cc851fb9f644b17a8ebf4d99a646003769a22f
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CEP192 RFWD3 DGCR8 PKN3 TBCD KIF22	6.04e-05	190	158	6	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	facs-Pancreas-Exocrine-3m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL AFAP1L1 EHD2 TRIL FGD5 PKN3	6.04e-05	190	158	6	5f440d4b334d66d419c03bd828f7d93f16c1ce67
ToppCell	Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|World / Lineage, Cell type, age group and donor	NES PODXL AFAP1L1 FGD5 CX3CL1 PKN3	6.40e-05	192	158	6	1e156bab5ecf64627890d2de9b27603d9a01f28d
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZBTB7C PODXL RALYL CRTAC1 FGD5 CHST7	6.40e-05	192	158	6	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SECISBP2L MAP1A FBXO2 PTPRD RNF5 CDC42EP2	6.59e-05	193	158	6	4274c95cedad2ae8c6693ad00deda2b1ba5b5682
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	NES PODXL AFAP1L1 FGD5 CX3CL1 PKN3	6.59e-05	193	158	6	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CEP192 RFWD3 PRKCA PKN3 TBCD KIF22	6.59e-05	193	158	6	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	(6)_Endothelial-B_(Artery)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	NES PODXL PPFIA3 AFAP1L1 CX3CL1 PKN3	6.78e-05	194	158	6	0cf4e67d4024652794b5bfdd4a71a7d98900b4c8
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	FLYWCH1 PPFIA3 UBE2O BSN CX3CL1 UNC80	6.78e-05	194	158	6	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PODXL ARHGEF12 HERC2P3 AFAP1L1 FGD5 LEF1	6.78e-05	194	158	6	ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PODXL ARHGEF12 HERC2P3 AFAP1L1 FGD5 LEF1	6.78e-05	194	158	6	cceb7c88492bb6cd531e1c2651638da1ddf30931
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SECISBP2L ABCA3 PPP1R9A CRTAC1 AKAP13 GOLGA4	7.18e-05	196	158	6	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	ASK454-Endothelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	DOCK1 NES PODXL AFAP1L1 FGD5 CX3CL1	7.18e-05	196	158	6	14dd6956ef420b660be0baf52a66960e57d75d16
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NES PODXL CRTAC1 ARHGAP4 NUDT10 FGD5	7.59e-05	198	158	6	f88198e11e835ad53d339c312f8f7b7b0b5c02d3
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	APBA2 SKP1 NLRP6 PRKCA LEF1 SORL1	7.59e-05	198	158	6	db107a5511571384f26e26c6301aef9a9f2423c4
ToppCell	cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MIER2 NES PODXL AFAP1L1 CDC42EP2 CX3CL1	7.80e-05	199	158	6	9364199c5b4540ce2e14341fd9d504b695f8249d
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NES PODXL AFAP1L1 EHD2 CX3CL1 HSPB8	7.80e-05	199	158	6	7ed541309808f15d65a9c4b26be2050e077539e6
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A PTPRD PTPRS ARNT2 ROBO1 PLXNB1	7.80e-05	199	158	6	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	cellseq-Endothelial-Endothelial_Vascular-Endothelial_capillary\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MIER2 NES PODXL AFAP1L1 CX3CL1 HSPB8	7.80e-05	199	158	6	5f67ea58512856cbdcef759088a5869720a947a8
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A PTPRD PTPRS ARNT2 ROBO1 PLXNB1	7.80e-05	199	158	6	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	Transverse-T_cell-Tfh\|Transverse / Region, Cell class and subclass	FLYWCH1 APBA2 CLIC6 PLEKHG3 RABGAP1L LEF1	7.80e-05	199	158	6	cbef8f95edf2e86e16c448a76068d7ed8f6b7748
ToppCell	Transverse-(1)_T_cell-(16)_Tfh\|Transverse / shred on region, Cell_type, and subtype	FLYWCH1 APBA2 CLIC6 PLEKHG3 RABGAP1L LEF1	7.80e-05	199	158	6	aa31e26d48066f865ca33251a33a28934c0a7a44
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MIER2 NES PODXL AFAP1L1 CX3CL1 HSPB8	7.80e-05	199	158	6	82758d0cee9387d002e3f68a6faa324134fb7564
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A PTPRD PTPRS ARNT2 ROBO1 PLXNB1	7.80e-05	199	158	6	6fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A PTPRD PTPRS ARNT2 ROBO1 PLXNB1	7.80e-05	199	158	6	1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell	Hematolymphoid-Endothelial-NOSTRIN\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 PODXL EHD2 ARNT2 KIAA1755 LEF1	8.02e-05	200	158	6	032df80aa5c40991e1c1e80f9d8da106e6aeaee2
ToppCell	medial-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MIER2 NES PODXL AFAP1L1 CX3CL1 HSPB8	8.02e-05	200	158	6	a8adf5902540f6bb15b72efbb9c389b59d67e001
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZBTB7C PODXL CLIC6 ZNHIT6 PER2 CX3CL1	8.02e-05	200	158	6	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	Hematolymphoid-Endothelial-NOSTRIN---\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 PODXL EHD2 ARNT2 KIAA1755 LEF1	8.02e-05	200	158	6	68fce28690246895fd33354b30960ebcc31aa4cc
ToppCell	medial-Endothelial-Capillary_Intermediate_1\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MIER2 NES PODXL AFAP1L1 CX3CL1 HSPB8	8.02e-05	200	158	6	3ef7b7728615710c691aed8977e2582f19692cf9
ToppCell	Hematolymphoid-Endothelial-NOSTRIN-\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 PODXL EHD2 ARNT2 KIAA1755 LEF1	8.02e-05	200	158	6	376b19ab5a7cd2c85f726d8ba41337d4525863e5
ToppCell	distal-2-Endothelial-Capillary_Intermediate_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MIER2 NES PODXL EHD2 CX3CL1 HSPB8	8.02e-05	200	158	6	7a99f28670ffb8ece7873d8a9bcd2a3936d0255d
ToppCell	distal-Endothelial-Capillary_Intermediate_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NES PODXL AFAP1L1 CDC42EP2 CX3CL1 HSPB8	8.02e-05	200	158	6	43bc48413b100a06f8edd9acd812296788fcbf5b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm\|6m / Sample Type, Dataset, Time_group, and Cell type.	NES CACNB1 C1orf167 RYR1 AFAP1L1 HSPB8	8.02e-05	200	158	6	0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c
ToppCell	Hematolymphoid-Endothelial-NOSTRIN--\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 PODXL EHD2 ARNT2 KIAA1755 LEF1	8.02e-05	200	158	6	7fa54370221ed61bac0e09e6bcf1f3dff202a846
ToppCell	mild-CD8+_T_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	APBA2 CHD3 ST13 PRKCA ROBO1 LEF1	8.02e-05	200	158	6	c825320599a61a4c629d736f5c0fd6f1f405540a
ToppCell	distal-1-Endothelial-Capillary_Aerocyte\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MIER2 NES PODXL AFAP1L1 EHD2 CX3CL1	8.02e-05	200	158	6	59bacd738433cec6d05624a25fdfc087fb3ca3b5
ToppCell	distal-Endothelial-Capillary_Intermediate_1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NES PODXL AFAP1L1 CDC42EP2 CX3CL1 HSPB8	8.02e-05	200	158	6	4d6714d48738cdee7d535923f6dd2431e5304741
ToppCell	Hematolymphoid-Endothelial-NOSTRIN----L2-6\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 PODXL EHD2 ARNT2 KIAA1755 LEF1	8.02e-05	200	158	6	878bbbe32e3602723aa14ef32877ab2453b8c6e5
ToppCell	Hematolymphoid-Endothelial\|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic	DOCK1 PODXL EHD2 ARNT2 KIAA1755 LEF1	8.02e-05	200	158	6	7136936d05ab344a560cf159684c881063b5430d
ToppCell	medial-Endothelial-Capillary_Intermediate_1-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MIER2 NES PODXL AFAP1L1 CX3CL1 HSPB8	8.02e-05	200	158	6	707148e01e961097819a05437a842b7d3bf72b0a
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPOR E4F1 CEP192 ZNF710 SORL1	2.09e-04	152	158	5	0652ee3443e6fbb679d2c4f326239ae7c803f924
ToppCell	mild_COVID-19_(asymptomatic)-CD8+_T_naive\|World / disease group, cell group and cell class (v2)	APBA2 PPFIA3 TBCCD1 ROBO1 LEF1	2.09e-04	152	158	5	f944743f40ff6ed3a7a096dd53e12d3526c67c4d
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ZBTB7C PODXL CC2D1A AFAP1L1 CHST7	2.22e-04	154	158	5	212c340a096a3a9669d1aebd61c045cf1402a868
ToppCell	mild_COVID-19_(asymptomatic)-CD8+_T_naive\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	APBA2 PPFIA3 TBCCD1 ROBO1 LEF1	2.29e-04	155	158	5	e2c901d5c9e42d25d7702e5e8fc19b06f7c817be
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|356C / Donor, Lineage, Cell class and subclass (all cells)	NES ZBTB7C PTPRD KIAA1755 FGD5	2.29e-04	155	158	5	e1a20e88b9c0eaf7ca7004acc0eda096d1588563
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL AFAP1L1 FGD5 PKN3 TBCD	2.29e-04	155	158	5	59035d792c26d870a8b097939e97fa47859ba68c
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|368C / Donor, Lineage, Cell class and subclass (all cells)	CRTAC1 CEP192 RAB11FIP4 ZNF697 SORL1	2.36e-04	156	158	5	25b0936960be4955b6a6d6b8a867fdd4be548f05
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NES PODXL PPFIA3 FGD5 CX3CL1	2.36e-04	156	158	5	ff39712c7a2dc1b85c598d5105789aa291dea726
Drug	Bretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A	USB1 APBA2 NCAPH2 ARID1A RFWD3 ZNF710 PLEKHG3 RABGAP1L ADGRE5 TBCD JHY	1.14e-07	196	156	11	5020_DN
Drug	Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MAP1A USB1 ARHGEF12 FBXO11 PPFIA3 RYR1 EHD2 ARVCF PLEKHG3 DGCR8	9.11e-07	193	156	10	2764_UP
Drug	trichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A	AKAP8 PFAS ARID1A AXIN1 ZNF710 PER2 EIF4A1 C11orf68 CDC42EP2 DGCR8	9.11e-07	193	156	10	413_DN
Drug	Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A	CACNB1 MAP1A APBA2 NCAPH2 ITIH2 CREBZF AXIN1 CDC42EP2 PRKCA LEF1	1.15e-06	198	156	10	2178_UP
Drug	Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HG-U133A	FNBP4 NCAPH2 PPFIA3 AXIN1 ZNF710 NUDT11 ARVCF PLEKHG3 CDC42EP2 DGCR8	1.26e-06	200	156	10	1908_UP
Drug	pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A	MIER2 EPOR CACNB1 MAP1A PPFIA3 RYR1 FBXO2 ARVCF JHY	7.98e-06	194	156	9	7523_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; PC3; HG-U133A	EPOR CACNB1 NOL6 ARVCF PLEKHG3 CDC42EP2 PRKCA CHST7 INO80B	8.32e-06	195	156	9	433_UP
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	EPOR SETD1A AKAP8 FBXO11 GCDH PPFIA3 RABGAP1L CDC42EP2 DGCR8	8.67e-06	196	156	9	1531_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	SETD1A CACNB1 NOL6 NCAPH2 ITIH2 ZNF710 PRKCA HEMK1 JHY	9.03e-06	197	156	9	6143_DN
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A	EPOR POLG ARHGEF12 FBXO11 CRTAC1 NCAPH2 ZNF710 ARVCF PLEKHG3	9.03e-06	197	156	9	1408_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	EPOR SETD1A POLG PPFIA3 AXIN1 ZNF710 FANCE AKAP13 PLXNB1	9.03e-06	197	156	9	7440_DN
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; HL60; HG-U133A	EPOR WIPI1 POLG CRTAC1 ITIH2 AXIN1 PLEKHG3 PRKCA HEMK1	9.41e-06	198	156	9	1412_UP
Drug	Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	DOCK1 SETD1A NCAPH2 HNRNPU EHD2 ADGRE5 DGCR8 INO80B JHY	9.41e-06	198	156	9	3313_DN
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	SETD1A MAP1A USB1 AXIN1 ZNF710 AKAP13 PLXNB1 INO80B TBCD	9.79e-06	199	156	9	4297_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HG-U133A	TFEB SETD1A CACNB1 POLG ARID1A AXIN1 ZNF710 KLHL11 UBE2O	9.79e-06	199	156	9	348_DN
Drug	PP-IP(5	ARHGAP4 NUDT11 NUDT3 NUDT10	1.41e-05	22	156	4	CID000127296
Drug	trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A	EXOSC10 AKAP8 POLG PFAS ARID1A ZNF710 ARVCF DGCR8	3.37e-05	179	156	8	332_DN
Drug	adenosine 5'-tetraphosphate	NUDT11 NUDT10	4.66e-05	2	156	2	ctd:C017991
Drug	diadenosine 5',5''''-P1,P6-hexaphosphate	NUDT11 NUDT10	4.66e-05	2	156	2	ctd:C070070
Drug	adenosine 5'-pentaphosphate	NUDT11 NUDT10	4.66e-05	2	156	2	ctd:C048567
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	NES CC2D1A NCAPH2 ZNF592 PLEKHG3 CDC42EP2 HSPB8 INO80B	4.95e-05	189	156	8	6997_DN
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	EPOR WDR33 HNRNPU ZNF710 PLEKHG3 AKAP13 ADGRE5 HEMK1	5.95e-05	194	156	8	5665_DN
Drug	Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A	ARID1A CREBZF ARVCF AKAP13 ADGRE5 STRA6 INO80B JHY	5.95e-05	194	156	8	4848_DN
Drug	0173570-0000 [211245-44-2]; Down 200; 1uM; MCF7; HT_HG-U133A	USB1 HNRNPU ARHGAP4 PER2 ARVCF RABGAP1L CDC42EP2 JHY	5.95e-05	194	156	8	4715_DN
Drug	SC 19220; Up 200; 10uM; PC3; HT_HG-U133A	SETD1A ARHGEF12 NCAPH2 PPFIA3 HNRNPU ZNF592 HEMK1 DGCR8	5.95e-05	194	156	8	7065_UP
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	NCAPH2 PPFIA3 CREBZF ZNF710 ARHGAP4 ARVCF PLEKHG3 PLXNB1	5.95e-05	194	156	8	1480_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	USB1 PFAS NCAPH2 HNRNPU ZNF710 FANCE RABGAP1L INO80B	5.95e-05	194	156	8	5216_DN
Drug	S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; PC3; HT_HG-U133A	SECISBP2L WDR33 POLG NCAPH2 PPFIA3 ARVCF HEMK1 LEF1	6.17e-05	195	156	8	6299_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	USB1 APBA2 NCAPH2 ARVCF PRKCA ADGRE5 PLXNB1 TBCD	6.17e-05	195	156	8	3941_DN
Drug	Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	CACNB1 ABCA3 USB1 WDR33 ARID1A PLEKHG3 RABGAP1L INO80B	6.17e-05	195	156	8	6330_UP
Drug	Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	DOCK1 SETD1A CACNB1 FBXO11 ARHGAP4 PTPRS AKAP13 ADGRE5	6.39e-05	196	156	8	7025_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	NOL6 LARP1 CHD3 ITIH2 AXIN1 HEMK1 DGCR8 INO80B	6.39e-05	196	156	8	4292_DN
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A	SETD1A NES CHD3 PPFIA3 ARID1A CREBZF CDC42EP2 HEMK1	6.39e-05	196	156	8	1511_DN
Drug	Cromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; PC3; HT_HG-U133A	DOCK1 EPOR POLG PPFIA3 AXIN1 FBXO2 ZNF710 AKAP13	6.39e-05	196	156	8	5754_DN
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; PC3; HT_HG-U133A	SETD1A CACNB1 RABGAP1L ARNT2 PRKCA DGCR8 LEF1 JHY	6.39e-05	196	156	8	4597_UP
Drug	Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A	MAP1A FBXO2 HNRNPU ZNF710 ARVCF PTPRS RABGAP1L JHY	6.63e-05	197	156	8	7351_UP
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	POLG APBA2 NCAPH2 RABGAP1L CDC42EP2 AKAP13 INO80B JHY	6.63e-05	197	156	8	6012_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A	SETD1A ARHGEF12 CHD3 NCAPH2 RYR1 FBXO2 RABGAP1L AKAP13	6.63e-05	197	156	8	5276_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; PC3; HT_HG-U133A	POLG ITIH2 CREBZF ARVCF ARNT2 PRKCA STRA6 JHY	6.63e-05	197	156	8	5747_UP
Drug	U0125; Down 200; 1uM; PC3; HG-U133A	EPOR ABCA3 NOL6 PPFIA3 AXIN1 NUDT11 ARVCF DGCR8	6.63e-05	197	156	8	663_DN
Drug	Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SECISBP2L INTS1 CHD3 NCAPH2 UBE2O PRKCA AKAP13 TBCD	6.63e-05	197	156	8	7185_DN
Drug	Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; PC3; HT_HG-U133A	TFEB EPOR ABCA3 POLG NCAPH2 FBXO2 PLEKHG3 INO80B	6.63e-05	197	156	8	4022_DN
Drug	Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A	SECISBP2L EPOR NES NOL6 GCDH NCAPH2 XPNPEP1 CDC42EP2	6.87e-05	198	156	8	5531_DN
Drug	Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A	EPOR WIPI1 USB1 FBXO11 ARID1A FBXO2 ZNF710 PRKCA	6.87e-05	198	156	8	5399_UP
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	EPOR CHD3 NCAPH2 PPFIA3 ZNF710 ARVCF PLEKHG3 INO80B	6.87e-05	198	156	8	1491_DN
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A	SETD1A AKAP8 POLG NOL6 NCAPH2 CREBZF HNRNPU AKAP13	6.87e-05	198	156	8	3259_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A	KRT12 PPP1R9A APBA2 ITIH2 ZNF710 EHD2 INO80B JHY	6.87e-05	198	156	8	6503_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	EPOR SETD1A USB1 APBA2 ARID1A PRKCA DGCR8 TBCD	6.87e-05	198	156	8	3405_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	USB1 APBA2 CREBZF FANCE ARVCF PTPRS PLEKHG3 STRA6	6.87e-05	198	156	8	6053_DN
Drug	Dacarbazine [4342-03-4]; Up 200; 22uM; HL60; HG-U133A	CACNB1 POLG NOL6 CC2D1A GCDH ZNF710 PRKCA DGCR8	6.87e-05	198	156	8	1762_UP
Drug	alpha-estradiol; Down 200; 0.01uM; PC3; HG-U133A	EPOR POLG INTS1 ZNF629 APBA2 NCAPH2 NUDT11 TRAPPC12	6.87e-05	198	156	8	702_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Down 200; 8.4uM; MCF7; HT_HG-U133A	NES WIPI1 PPFIA3 FANCE RABGAP1L ARNT2 CDC42EP2 HEMK1	6.87e-05	198	156	8	7013_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; PC3; HG-U133A	CACNB1 PPFIA3 AXIN1 FANCE NUDT11 CDC42EP2 AKAP13 ADGRE5	7.11e-05	199	156	8	1888_UP
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A	EPOR NES ARHGEF12 PPFIA3 CREBZF PPP1R26 AKAP13 INO80B	7.11e-05	199	156	8	7009_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; HL60; HG-U133A	USB1 APBA2 LARP1 GCDH CHD3 NCAPH2 ARHGAP4 HEMK1	7.11e-05	199	156	8	1586_DN
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A	CACNB1 MAP1A POLG NCAPH2 ARVCF DGCR8 CHST7 PLXNB1	7.11e-05	199	156	8	7461_UP
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A	NOL6 NCAPH2 CREBZF ZNF710 CDC42EP2 AKAP13 ADGRE5 PLXNB1	7.11e-05	199	156	8	1509_DN
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; HL60; HT_HG-U133A	SETD1A CACNB1 MAP1A USB1 NCAPH2 CREBZF ZNF710 LEF1	7.11e-05	199	156	8	2386_DN
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	TFEB POLG ARHGEF12 CREBZF ARVCF HEMK1 DGCR8 PLXNB1	7.11e-05	199	156	8	3879_DN
Drug	Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A	TFEB EPOR WDR33 RALYL CC2D1A ITIH2 DGCR8 LEF1	7.11e-05	199	156	8	2320_UP
Drug	Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; MCF7; HT_HG-U133A	MAP1A CC2D1A NCAPH2 FBXO2 ZNF710 PLEKHG3 RABGAP1L JHY	7.37e-05	200	156	8	7329_UP
Drug	Butacaine [149-16-6]; Up 200; 13uM; MCF7; HT_HG-U133A	PPFIA3 ARID1A CREBZF EHD2 RABGAP1L ADGRE5 DGCR8 CHST7	7.37e-05	200	156	8	6225_UP
Drug	6-thioguanine; Up 200; 10uM; MCF7; HG-U133A	CACNB1 PODXL POLG NOL6 NCAPH2 PTPRD ARVCF SORL1	7.37e-05	200	156	8	642_UP
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	USB1 FBXO11 CC2D1A CHD3 NCAPH2 TRAPPC12 PLEKHG3 HEMK1	7.37e-05	200	156	8	7182_DN
Drug	6-aminothymine	RRM2B TYMP	1.39e-04	3	156	2	CID000065245
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	EXOSC10 LARP1 ARID1A AXIN1 ZNF710 PER2 C11orf68	2.32e-04	178	156	7	1672_DN
Drug	tetraphenylboron	TFEB KRT12 TYMP	2.39e-04	18	156	3	CID000008934
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	AKAP8 CHD3 ARID1A NCBP3 TRAPPC12 EIF4A1 HSPB8	2.40e-04	179	156	7	2105_DN
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A	EPOR SETD1A WIPI1 CHD3 ROBO1 HEMK1 STRA6	2.75e-04	183	156	7	3480_UP
Drug	P(1),P(5)-di(adenosine-5'-)pentaphosphate	NUDT11 NUDT10	2.77e-04	4	156	2	ctd:C012275
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	FBXO11 AXIN1 ZNF710 TRAPPC12 PLEKHG3 ADGRE5 CHST7	3.34e-04	189	156	7	1651_DN
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	USB1 PPP1R9A CC2D1A CHD3 NCAPH2 CREBZF FANCE	3.56e-04	191	156	7	4969_DN
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; HL60; HT_HG-U133A	SETD1A CACNB1 NCAPH2 ZNF710 RABGAP1L DGCR8 TBCD	3.56e-04	191	156	7	2499_DN
Drug	Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	EPOR NES PPFIA3 HNRNPU PLXNB1 INO80B TBCD	3.68e-04	192	156	7	3505_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	EPOR USB1 FBXO11 NCAPH2 PPFIA3 RABGAP1L STRA6	3.68e-04	192	156	7	6025_DN
Drug	Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A	ARID1A ITIH2 AXIN1 ARNT2 DGCR8 STRA6 INO80B	3.79e-04	193	156	7	3086_UP
Drug	geldanamycin; Down 200; 1uM; MCF7; HG-U133A	FBXO11 NCAPH2 EHD2 TRAPPC12 CDC42EP2 PRKCA PLXNB1	3.79e-04	193	156	7	593_DN
Drug	indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A	EPOR MAP1A ARID1A TYMP UBE2O DGCR8 JHY	3.79e-04	193	156	7	262_UP
Drug	Thioguanosine [85-31-4]; Up 200; 12.6uM; HL60; HT_HG-U133A	AKAP8 WDR33 PPFIA3 ZNF710 NCBP3 DGCR8 CHST7	3.91e-04	194	156	7	1264_UP
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A	NOL6 PFAS CREBZF AXIN1 HEMK1 INO80B TBCD	3.91e-04	194	156	7	2485_DN
Drug	Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; MCF7; HT_HG-U133A	FBXO11 CHD3 NCAPH2 HNRNPU ZNF710 ADGRE5 JHY	3.91e-04	194	156	7	7032_UP
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	DOCK1 EPOR FBXO11 CHD3 CREBZF PLEKHG3 HEMK1	3.91e-04	194	156	7	6779_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; HL60; HT_HG-U133A	CACNB1 USB1 CREBZF PRKCA CHST7 INO80B TBCD	3.91e-04	194	156	7	2711_DN
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A	EPOR FBXO11 NCAPH2 RYR1 FBXO2 ARVCF ADGRE5	3.91e-04	194	156	7	7347_UP
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; PC3; HT_HG-U133A	TFEB CACNB1 EHD2 ARVCF RABGAP1L PRKCA STRA6	3.91e-04	194	156	7	6628_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	CACNB1 ABCA3 NOL6 INTS1 NCAPH2 ARHGAP4 INO80B	4.03e-04	195	156	7	2805_UP
Drug	Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SECISBP2L POLG BAD PPFIA3 ARID1A FANCE INO80B	4.03e-04	195	156	7	7018_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	LARP1 GCDH CHD3 AXIN1 TRAPPC12 CDC42EP2 INO80B	4.03e-04	195	156	7	1700_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	CACNB1 NCAPH2 CREBZF PTPRS C11orf68 DGCR8 CHST7	4.03e-04	195	156	7	2208_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A	TFEB EPOR WDR33 CREBZF ARVCF HEMK1 PLXNB1	4.03e-04	195	156	7	3642_UP
Drug	Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SETD1A WIPI1 NCAPH2 ARID1A ZNF710 PRKCA DGCR8	4.03e-04	195	156	7	6235_UP
Drug	novobiocin sodium, USP; Down 200; 100uM; SKMEL5; HG-U133A	POLG GCDH AXIN1 HNRNPU UBE2O ARVCF TRNAU1AP	4.03e-04	195	156	7	632_DN
Drug	Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A	SECISBP2L USB1 PPFIA3 PLEKHG3 RABGAP1L CDC42EP2 DGCR8	4.03e-04	195	156	7	6828_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	TFEB EPOR AKAP8 NOL6 GCDH NCAPH2 ARHGAP4	4.03e-04	195	156	7	1144_DN
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	EPOR AKAP8 FBXO11 CREBZF AXIN1 HNRNPU STRA6	4.16e-04	196	156	7	1512_DN
Drug	Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A	DOCK1 NCAPH2 PPFIA3 CREBZF HNRNPU STRA6 INO80B	4.16e-04	196	156	7	5301_UP
Drug	Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A	MAP1A PPP1R9A INTS1 ARHGEF12 ARVCF EIF4A1 STRA6	4.16e-04	196	156	7	2781_UP
Drug	quercetin dihydrate; Up 200; 1uM; MCF7; HT_HG-U133A_EA	KRT12 MAP1A NCAPH2 PPFIA3 FBXO2 EHD2 RABGAP1L	4.16e-04	196	156	7	917_UP
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	EPOR CHD3 NCAPH2 ZNF710 PLEKHG3 CDC42EP2 SORL1	4.16e-04	196	156	7	7181_DN
Drug	3-nitropropionic acid; Up 200; 10uM; PC3; HT_HG-U133A	TFEB NCAPH2 CREBZF FBXO2 HNRNPU ARVCF HSPB8	4.16e-04	196	156	7	6372_UP
Disease	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME	POLG RRM2B TYMP	1.26e-07	3	149	3	C0872218
Disease	testosterone measurement	TFEB AMER1 NYAP2 MAP1A FNBP4 ZNF629 WDR81 FBXO11 CRTAC1 SSR2 ARID1A BIRC6 TRAPPC12 PRKCA LEF1 MYO16 PKN3 JHY MORN3	2.44e-05	1275	149	19	EFO_0004908
Disease	mitochondrial encephalomyopathy (is_implicated_in)	POLG TYMP	2.53e-05	2	149	2	DOID:890 (is_implicated_in)
Disease	Mitochondrial DNA Depletion Syndrome 1	POLG TYMP	2.53e-05	2	149	2	C4551995
Disease	Mitochondrial DNA depletion syndrome 1	POLG TYMP	2.53e-05	2	149	2	cv:C4551995
Disease	Visceral myopathy familial external ophthalmoplegia	RRM2B TYMP	2.53e-05	2	149	2	C1848586
Disease	MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE)	POLG TYMP	2.53e-05	2	149	2	603041
Disease	5-methyluridine (ribothymidine) measurement	NCAPH2 TYMP PTPRS	4.41e-05	14	149	3	EFO_0020013
Disease	response to anti-tuberculosis drug, drug-induced liver injury	PTPRD ROBO1	7.57e-05	3	149	2	EFO_0004228, EFO_0007918
Disease	mean corpuscular hemoglobin concentration	WIPI1 NYAP2 AKAP8 APOA5 PAGE2 LARP1 PFAS GCDH XPNPEP1 TYMP AXIN1 NLRP6 CC2D2A AKAP13 DOT1L MYO16	1.55e-04	1105	149	16	EFO_0004528
Disease	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1	POLG RRM2B	2.51e-04	5	149	2	C1834846
Disease	ferritin measurement	ZBTB7C FNBP4 AXIN1 PTPRD MYO16	3.53e-04	119	149	5	EFO_0004459
Disease	Malignant neoplasm of breast	EPOR ABCA3 AKAP8 RALYL ARID1A PTPRD PER2 TRAPPC12 NLRC5 ROBO1 BOD1L1 FGD5 LEF1 PLXNB1 SORL1	3.67e-04	1074	149	15	C0006142
Disease	intermittent claudication (biomarker_via_orthology)	BAD BAK1	3.75e-04	6	149	2	DOID:3669 (biomarker_via_orthology)
Disease	glaucoma (biomarker_via_orthology)	EPOR BAD HDAC1	3.77e-04	28	149	3	DOID:1686 (biomarker_via_orthology)
Disease	Bilateral Wilms Tumor	AMER1 ARID1A DGCR8	4.19e-04	29	149	3	C2930471
Disease	NAD-dependent protein deacetylase sirtuin-2 measurement	ITIH2 PRKCA	5.23e-04	7	149	2	EFO_0008241
Disease	hypothyroidism (biomarker_via_orthology)	PLOD3 MAP1A APOA5 BAD	7.33e-04	80	149	4	DOID:1459 (biomarker_via_orthology)
Disease	Nephroblastoma	AMER1 ARID1A DGCR8	7.97e-04	36	149	3	C0027708
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	NYAP2 MAP1A APOA5 CRTAC1 ARID1A NLRC5	9.97e-04	224	149	6	EFO_0004574, EFO_0008317
Disease	polymyositis (is_marker_for)	ROBO1 CX3CL1	1.35e-03	11	149	2	DOID:0080745 (is_marker_for)
Disease	lipid measurement, high density lipoprotein cholesterol measurement	WIPI1 NYAP2 MAP1A APOA5 ARID1A NUDT3 NLRC5	1.49e-03	330	149	7	EFO_0004529, EFO_0004612
Disease	platelet component distribution width	NYAP2 APOA5 ZNF629 CRTAC1 ZNF710 PWWP2A UBE2O ARVCF PLEKHG3 AKAP13 ADGRE5	1.62e-03	755	149	11	EFO_0007984
Disease	creatinine measurement	TFEB WIPI1 NYAP2 ARID1A BIRC6 RYR1 RFWD3 NUDT3 ZNF592 KIAA1755 BSN UNC80 SORL1	1.66e-03	995	149	13	EFO_0004518
Disease	brain ischemia (biomarker_via_orthology)	EPOR NES BAD PRKCA	1.81e-03	102	149	4	DOID:2316 (biomarker_via_orthology)
Disease	body weight	SECISBP2L DOCK1 ZBTB7C RALYL BAD ARHGEF12 CRTAC1 E4F1 CEP192 PPFIA3 AXIN1 NUDT3 RABGAP1L HEMK1 DOT1L	1.85e-03	1261	149	15	EFO_0004338
Disease	lipoprotein measurement	DOCK1 NYAP2 ARID1A NLRC5	2.01e-03	105	149	4	EFO_0004732
Disease	Impaired cognition	EIF2B5 SORL1	2.21e-03	14	149	2	C0338656
Disease	reticulocyte measurement	WIPI1 NYAP2 FLVCR1 LARP1 PFAS GCDH USP37 BIRC6 KLHL11 UBE2O NUDT3 AKAP13 BSN	2.71e-03	1053	149	13	EFO_0010700
Disease	alcohol dependence measurement	PODXL FGD5 MYO16	2.73e-03	55	149	3	EFO_0007835
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	WIPI1 NYAP2 APOA5 CRTAC1 BIRC6 NLRC5	2.86e-03	276	149	6	EFO_0004612, EFO_0020943
Disease	DiGeorge Syndrome	ARVCF DGCR8	2.90e-03	16	149	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	ARVCF DGCR8	2.90e-03	16	149	2	C0795907
Disease	Shprintzen syndrome	ARVCF DGCR8	2.90e-03	16	149	2	C0220704
Disease	myeloid white cell count	ARHGEF12 SSR2 UBE2O ARVCF RABGAP1L NLRC5 KIAA1755 ADGRE5 DOT1L PLXNB1 PKN3 SORL1	2.93e-03	937	149	12	EFO_0007988
Disease	free androgen index	TFEB NYAP2 FNBP4 ARID1A PRKCA PKN3 JHY	3.00e-03	374	149	7	EFO_0007005
Disease	Colorectal Carcinoma	CACNB1 ABCA3 ARID1A TYMP ZNHIT6 PTPRD PTPRS LEF1 DNAH8 SORL1	3.09e-03	702	149	10	C0009402
Disease	free cholesterol in medium HDL measurement	NYAP2 ARID1A NLRC5	3.18e-03	58	149	3	EFO_0022267
Disease	Muscle hypotonia	RRM2B INTS1	3.28e-03	17	149	2	C0026827
Disease	dermatomyositis (is_marker_for)	ROBO1 CX3CL1	3.28e-03	17	149	2	DOID:10223 (is_marker_for)
Disease	cholesterol in medium HDL measurement	NYAP2 ARID1A NLRC5	3.34e-03	59	149	3	EFO_0021903
Disease	insulin resistance	DOCK1 NYAP2 PTPRD	3.34e-03	59	149	3	EFO_0002614
Disease	triglycerides to total lipids in large HDL percentage	NYAP2 ARID1A NLRC5	3.50e-03	60	149	3	EFO_0022330
Disease	phospholipids in HDL measurement	NYAP2 ARID1A NLRC5	3.67e-03	61	149	3	EFO_0022293
Disease	mean arterial pressure	NYAP2 PODXL ARHGEF12 IKZF4 PTPRD PRKCA ROBO1 FGD5	3.96e-03	499	149	8	EFO_0006340
Disease	total lipids in HDL measurement	NYAP2 ARID1A NLRC5	4.02e-03	63	149	3	EFO_0022307
Disease	sexual dimorphism measurement	NYAP2 APOA5 PODXL ARID1A ZNF710 FANCE NUDT3 ZNF592 C11orf68 NLRC5 RAB11FIP4 DOT1L BSN	4.10e-03	1106	149	13	EFO_0021796
Disease	renal cell carcinoma (is_marker_for)	BAD BAK1 PFAS TYMP	4.10e-03	128	149	4	DOID:4450 (is_marker_for)
Disease	Prostatic Neoplasms	PODXL BAD CHD3 SSR2 ARID1A ROBO1 AKAP13 CX3CL1 GOLGA4	4.19e-03	616	149	9	C0033578
Disease	Malignant neoplasm of prostate	PODXL BAD CHD3 SSR2 ARID1A ROBO1 AKAP13 CX3CL1 GOLGA4	4.19e-03	616	149	9	C0376358
Disease	hepatocellular carcinoma (is_marker_for)	PLOD3 FBXO11 PFAS ARID1A AXIN1 NLRC5	4.36e-03	301	149	6	DOID:684 (is_marker_for)
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	WIPI1 NYAP2 APOA5 ARID1A BIRC6 NLRC5	4.50e-03	303	149	6	EFO_0004612, EFO_0020945
Disease	exercise test	PTPRD PRKCA	4.53e-03	20	149	2	EFO_0004328
Disease	total lipids in very large HDL measurement	WIPI1 NYAP2 NLRC5	4.58e-03	66	149	3	EFO_0022312
Disease	very low density lipoprotein particle size measurement	NYAP2 APOA5 CRTAC1 ARID1A	4.70e-03	133	149	4	EFO_0008594

Protein segments in the cluster

Peptide	Gene	Start	Entry
ADPAQGVAPEMGLAD	C1orf167	1376	Q5SNV9
PEPPGAMAASEDEEE	CHMP3	191	Q9Y3E7
DDGGELADERPAFPM	ARVCF	306	O00192
PEDEALTPGDECMDG	BIRC6	4041	Q9NR09
GDSCVDMETDPSEGP	CACNB1	516	Q02641
GPPDPDDLAQEMEDV	AAMP	36	Q13685
YPAGTEDDEGMGEEP	BAD	76	Q92934
EDDEGMGEEPSPFRG	BAD	81	Q92934
EVSAGQMPGPAEAEL	HTR3E	386	A5X5Y0
PVGAEAGPEDMEDGD	SH3BP5L	291	Q7L8J4
EQEAEGVAAPADPEM	BAK1	46	Q16611
VDPEMEGDDNLGGED	AKAP8	551	O43823
PFVERGPDEAMEDGE	EHD2	421	Q9NZN4
DELMEAPGDVEALAP	ADGRE5	306	P48960
MGAEGRESESEPADP	AKAP13	1516	Q12802
GAMDPSDGIGALIEE	ABCA3	876	Q99758
QGGGEEMALPDDDDE	AMER1	366	Q5JTC6
TEEGAGPDPQMLSEE	APOA5	266	Q6Q788
DLGPSGPSEENFDME	CUEDC2	41	Q9H467
SEDMELPLEGYVPEG	APBA2	31	Q99767
GPADAPMDSGAEEEK	DOT1L	366	Q8TEK3
AELEFPLDEPDSMGA	DGCR8	386	Q8WYQ5
EAEGPAGDSMDAEGP	CLIC6	271	Q96NY7
MLPAVGSVDEEEDPA	CBWD5	1	Q5RIA9
PTMEPEGGLDDSGEH	ARHGEF12	1366	Q9NZN5
PAGMTIPEEDADVGQ	ARNT2	291	Q9HBZ2
EGVIEPDTDAPQEMG	ST13P5	86	Q8NFI4
EGVIEPDTDAPQEMG	ST13	86	P50502
GMEPEEEPGGAAVRE	NUDT10	51	Q8NFP7
EEPAEGGPDADGEEM	RALYL	256	Q86SE5
GPSEVMAGPAEEAGA	TP53I13	21	Q8NBR0
EPLLPSASMDEEEGD	RFWD3	271	Q6PCD5
EDEEEAMTLAPPEGP	RAB11FIP4	136	Q86YS3
GGGDPELCATDEMIP	LEF1	11	Q9UJU2
PAPMEGGEEEEELLG	ARID1A	1756	O14497
GPEEALSPGEARDMA	PLOD3	361	O60568
GDQGPPEEAEDRFSM	PODXL	446	O00592
LEDFRVDPPMGEEGN	LARP1	1021	Q6PKG0
AAEQESGELDPGMEP	MAP1A	2281	P78559
EDLGLMGAQEPTGEE	MAGEA9	21	P43362
GNGMEPDSLDEEESP	JHY	66	Q6NUN7
VGGPGEVSVEMDAAP	KRT12	276	Q99456
PPMEEDVGDTDVLQG	INTS1	1011	Q8N201
ENEAGDERMLADAPP	ITIH2	631	P19823
MQAIPEDAIPEESGD	HDAC1	381	Q13547
MDDDAAPRVEGVPVA	KAAG1	1	Q9UBP8
PPGDEDDSEPVYIEM	MYO16	1401	Q9Y6X6
PPSDMDSEAEDLVGN	GOLGA4	116	Q13439
ASIEEFEKADPPGGM	KIAA1755	741	Q5JYT7
PDEHQDMDADPGGPE	FLYWCH1	406	Q4VC44
PAALDGGEEGMDIIT	HEMK1	261	Q9Y5R4
PGELDGSDEEEAEGM	PPFIA3	571	O75145
LDDGFGMDPFPDDLT	HSPB8	31	Q9UJY1
EEPAGALDLTGMRPE	BSN	1881	Q9UPA5
MLPAVGSADEEEDPA	CBWD2	1	Q8IUF1
MLPAVGSADEEEDPA	CBWD1	1	Q9BRT8
EEPDSRGGSPQMDDI	EIF2B5	536	Q13144
MDGDGDPESVGQPEE	FBXO2	1	Q9UK22
DNGPDGMEPEGVIES	EIF4A1	11	P60842
PELEMVEDAASGPES	PER2	686	O15055
PGERTPMLEDVDEGG	PLXNB1	1866	O43157
GGMEPEEEPSVAAVR	NUDT3	51	O95989
EEEEIGSPEPMAAPA	KIF22	406	Q14807
EMPEPTGDEPEDSVF	DNAH8	2741	Q96JB1
EGSGPDRPTEDMGQD	FGD5	231	Q6ZNL6
DMGQDAEDTSEEPPE	FGD5	241	Q6ZNL6
ALDDEEAGGRPAMEP	HNRNPU	41	Q00839
GAAGAADSGPMEEEE	HNRNPU	111	Q00839
RGATGEPEVMEPALE	NOL6	11	Q9H6R4
EGAGAPGDPMDQEDL	POLG	516	P54098
GVDRGEPEPMEVEEG	NCBP3	31	Q53F19
PPGMAGVENEDEAEL	NES	966	P48681
ECEDGPDGQEMDPPN	GAGE2D;	86	Q9UEU5
EDEPGDGPDVREGIM	PAGE2B	81	Q5JRK9
ECEDGPDGQEMDPPN	GAGE2A	86	Q6NT46
GMEPEEEPGGAAVRE	NUDT11	51	Q96G61
MGSPAGDPEEEEPVY	NYAP2	231	Q9P242
FDGLDEALQPMGPDG	NLRC5	306	Q86WI3
GGPMSPQDDEAEEES	RABGAP1L	476	Q5R372
SGAMEAPEPGEALEL	INO80B	11	Q9C086
GAEDLTPEDDMPVGR	PTPRS	281	Q13332
GLMDPVDPEDSVDLG	PASD1	336	Q8IV76
EGDPSVTPAEEMGDT	BOD1L1	2276	Q8NFC6
DGEMVLPGFPDADSF	EXOSC10	21	Q01780
AMEASGGDPGPEAED	KLHL11	56	Q9NVR0
PGTMVEGPEEDGTFD	CDC42EP2	66	O14613
EEEEPPAQGGGKEMD	CC2D2A	226	Q9P2K1
ELNGMTGADVADVPP	DOCK1	1786	Q14185
MDGVEVPEENVLPGA	GCDH	266	Q92947
VPADMVAEESGPGAQ	FBXO11	81	Q86XK2
DMDEPPPLDYGSGED	CHD3	586	Q12873
QDMDEDDGRDAAPPG	AXIN1	251	O15169
EEGSGQRPEEIPMDL	ZNHIT6	61	Q9NWK9
MLPAVGSVDEEEDPA	CBWD3	1	Q5JTY5
MLPAVGSVDEEEDPA	CBWD6	1	Q4V339
DLSPDGLMIPEDGAN	CC2D1A	26	Q6P1N0
MARPDDEEGAAVAPG	FLVCR1	1	Q9Y5Y0
FDLMGLSPDAPEDEA	LYPLA2	76	O95372
LQMETAGPEEEPAGA	CEP192	121	Q8TEP8
TMQAVEPGTDDEGPL	EPOR	341	P19235
GNVGPDALIEMDPEA	CRTAC1	201	Q9NQ79
EAELGDGEMAEAPGS	E4F1	151	Q66K89
MATPDAGLPGAEGVE	FANCE	1	Q9HB96
REPPEGSLLDVDMDG	FAM83H	76	Q6ZRV2
GDDGLPAPMEAEAYE	FAM83H	596	Q6ZRV2
YKVSDSPPGEDDMEG	RYR1	4581	P21817
SPPGEDDMEGSAAGD	RYR1	4586	P21817
TESPMGALQPDEAEE	PRRT3	381	Q5FWE3
GQPGDEIRDLEMVPD	IKZF4	286	Q9H2S9
SAAPEEAMGPAEEPE	NLRP6	156	P59044
LEEEAGEGGQDMPEA	DIPK1C	131	Q0P6D2
ESEGGDVAPNLPDMT	MIER2	106	Q8N344
GTMIDFGRDEAPEPT	MORN3	196	Q6PF18
EDEPGDGPDVREGIM	PAGE2	81	Q7Z2X7
EMLVGECPFPGDTEE	PKN3	751	Q6P5Z2
LGAEDLTPEDDMPIG	PTPRD	271	P23468
DMDEAEEGYPPATGP	MAP3K15	1151	Q6ZN16
AERDVPDPQEGVGME	NUTM2E	656	B1AL46
SVGTEEMPEDGEPDA	SYVN1	586	Q86TM6
GEGGAGEAEPEMEPI	PWWP2A	16	Q96N64
DEDAPMITGFSDDVP	SORL1	2196	Q92673
VGDDALEDPMPQLDV	TRNAU1AP	236	Q9NX07
PSEEGPGEALMLGAE	TFEB	351	P19484
MAAAEEEDGGPEGPN	RNF5	1	Q99942
EMEDEGSEEPPAPGT	FNBP4	741	Q8N3X1
MLAGQPPFDGEDEDE	PRKCA	531	P17252
KPVGPEDMGATADFE	RNF113B	101	Q8IZP6
EEMGGAAQEPESLLP	PLEKHG3	581	A1L390
ECEDGPDGQEMDPPN	GAGE2B	86	Q13066
GLSMDGEEAPAPEDV	SAMD11	526	Q96NU1
EEAEAPEVLEPGMDS	SECISBP2L	1051	Q93073
DPMGEEETTDFGPLV	PPP1R26	106	Q5T8A7
SPPEVEGAMAVNDGL	SYCE1L	181	A8MT33
DGAVVSPDLGDMSPE	HERC2P3	1071	Q9BVR0
DDMEISDDDRGGSPP	SETD1A	581	O15047
LGADNEPELEAEMPA	ARHGAP4	726	P98171
APQDSLRPGEEDEGM	STRA6	601	Q9BX79
MPEDDGEPSKGASPE	AFAP1L1	86	Q8TED9
GDAEQPREGETPLEM	CHST7	466	Q9NS84
PREGETPLEMDADGA	CHST7	471	Q9NS84
MPLGGGEDEDAEEAV	NCAPH2	251	Q6IBW4
RMEPGEELEEEGSPG	C11orf68	41	Q9H3H3
MGDPERPEAAGLDQD	RRM2B	1	Q7LG56
APGDSGERSEGEAME	ZNF511	191	Q8NB15
DDSFPPEDFGIVSGM	SSR2	61	P43308
EPEGEAMDAELAVAP	USP22	6	Q9UPT9
DEPLEAGMIVTDEPG	XPNPEP1	511	Q9NQW7
EPSIEPEGMSNAGAE	UNC80	1436	Q8N2C7
MEDAGGGEETPAPEA	TRAPPC12	1	Q8WVT3
GGDPNEDAAEMGPDS	PFAS	1171	O15067
GSAIAEAPSEMPGDE	ZNF592	411	Q92610
EAPSEMPGDEVPVEE	ZNF592	416	Q92610
PEEGSGEEVPMETRE	ZNF592	1201	Q92610
AGEEMTPPAGLAEEL	TRIL	436	Q7L0X0
PDGSASPVEMQDEGA	UBE2O	436	Q9C0C9
GGVAVRAPSPEEMEE	CREBZF	71	Q9NS37
DLGPELSGAAMGEPE	ZNF710	46	Q8N1W2
MDDEGDDDPVPLPNV	SKP1	36	P63208
GPLVSDMDTDAPEEE	ROBO1	1316	Q9Y6N7
NMFPGTEEGPEDDST	USB1	51	Q9BQ65
EGDPEEREMGSNPHD	ZNF697	31	Q5TEC3
PDTGFAEDDIQEMPE	USP37	736	Q86T82
IMEPGGDGGEEDDKE	ZBTB7C	126	A1YPR0
ELGTEMLGDLEEEGP	ZNF212	191	Q9UDV6
AMFSAPVDEKPGGEE	TSPYL6	156	Q8N831
PVDEKPGGEEMDVAE	TSPYL6	161	Q8N831
MALSDEPAAGGPEEE	TBCD	1	Q9BTW9
IPFEMEGDTTEIPGG	TBCCD1	471	Q9NVR7
MEAEAADAPPGGVES	WIPI1	1	Q5MNZ9
PGMSEDGVEYDDLEP	WDR33	421	Q9C0J8
GEEIIMGDPAQSPES	ZNF629	41	Q9UEG4
EVEEALLCMDGAGPP	TYMP	286	P19971
PGSCAFGEEIPMDGE	WDR81	1041	Q562E7
TAGPEEAPMREAEAG	nan	6	Q6ZQT7
PAAGGMDESVVLEPE	CX3CL1	116	P78423
DEVGPVLPGSDMAIE	PPP1R9A	641	Q9ULJ8